Page 174 - EJMO-9-1

Eurasian Journal of Medicine and
Oncology
Key signaling proteins in cardiovascular disease

The mouse genome database: Genotypes, phenotypes, Pap Rep. 2019;37(2):103-118.
and models of human disease. Nucleic Acids Res. 38. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene
2012;41(D1):D885-D891.
dose of apolipoprotein E type 4 allele and the risk of
doi: 10.1093/nar/gks1115 Alzheimer’s disease in late onset families. Science. 1993;
27. Wang Y, Miao X, Liu Y, et al. Dysregulation of histone 261(5123):921-923.
acetyltransferases and deacetylases in cardiovascular doi: 10.1126/science.8346443
diseases. Oxid Med Cell Longev. 2014;2014:641979.
39. Martins IJ, Hone E, Foster JK, et al. Apolipoprotein E,
doi: 10.1155/2014/641979 cholesterol metabolism, diabetes, and the convergence
28. Kong P, Cui ZY, Huang XF, Zhang DD, Guo RJ, Han M. of risk factors for Alzheimer’s disease and cardiovascular
Inflammation and atherosclerosis: Signaling pathways and disease. Mol Psychiatry. 2006;11(8):721-736.
therapeutic intervention. Signal Transduct Target Ther. doi: 10.1038/sj.mp.4001854
2022;7(1):131.
40. Fattakhov N, Smirnova L, Atochin D, et al. Haplotype analysis
doi: 10.1038/s41392-022-00955-7 of endothelial nitric oxide synthase (NOS3) genetic variants
29. Pang M, Zhang G, Shang C, et al. Advances in the study of and metabolic syndrome in healthy subjects and schizophrenia
KRAS in brain arteriovenous malformation. Cerebrovasc patients. Int J Obes (Lond). 2018;42(12):2036-2046.
Dis. 2024;53(6):767-775. doi: 10.1038/s41366-018-0124-z
doi: 10.1159/000535139 41. Baleydier F, Bernard F, Ansari M. The possibilities
30. Zekavat SM, Viana-Huete V, Matesanz N, et al. TP53- of immunotherapy for children with primary
mediated clonal hematopoiesis confers increased risk immunodeficiencies associated with cancers. Biomolecules.
for incident atherosclerotic disease. Nat Cardiovasc Res. 2020;10(8):1112.
2023;2(2):144-158. doi: 10.3390/biom10081112
doi: 10.1038/s44161-022-00206-6 42. Cortellaro M, Boschetti C, Cofrancesco E, et al. The PLAT
31. Mercer J, Bennett M. The role of p53 in atherosclerosis. Cell study: Hemostatic function in relation to atherothrombotic
Cycle. 2006;5(17):1907-1909. ischemic events in vascular disease patients. Principal results.
PLAT Study Group. Progetto Lombardo Atero-Trombosi
doi: 10.4161/cc.5.17.3166 (PLAT) Study Group. Arterioscler Thromb. 1992;12(9):
32. Liu PY, Death AK, Handelsman DJ. Androgens and 1063-1070.
cardiovascular disease. Endocr Rev. 2003;24(3):313-340. doi: 10.1161/01.atv.12.9.1063
doi: 10.1210/er.2003-0005 43. Gabay C, Towne JE. Regulation and function of
33. Shelkowitz E, Chan CM, Jones T, Nakano SJ, Meeks NJL. interleukin-36 cytokines in homeostasis and pathological
A novel GNAS variant presents with disorders of GNAS conditions. J Leucoc Biol. 2015;97(4):645-652.
inactivation and cardiomyopathy. Am J Med Genet A. doi: 10.1189/jlb.3RI1014-495R
2022;188(7):2147-2152.
44. Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation,
doi: 10.1002/ajmg.a.62726 immunity, and disease. Cold Spring Harb Perspect Biol.
34. Matsusaka H, Ide T, Matsushima S, et al. Targeted deletion 2014;6(10):a016295.
of p53 prevents cardiac rupture after myocardial infarction doi: 10.1101/cshperspect.a016295
in mice. Cardiovasc Res. 2006;70(3):457-465.
45. Tsukamoto M, Suzuki K, Seta N, Takeuchi T. Increased
doi: 10.1016/j.cardiores.2006.02.001 circulating CD14brightCD16+ intermediate monocytes
35. Hazarika D, Zimmermann R, Poria S. Misa: Modality- are regulated by TNF-α and IL-6 axis in accordance with
invariant and-specific Representations for Multimodal disease activity in patients with rheumatoid arthritis. Clin
th
Sentiment Analysis. In: Proceedings of the 28 ACM Exp Rheumatol. 2018;36(4):540-544.
International Conference on Multimedia; 2020. 46. Li J, Ma S, Chen J, et al. GSK-3β contributes to parkinsonian
36. Lu Y, Boer JM, Barsova RM, et al. TGFB1 genetic dopaminergic neuron death: Evidence from conditional
polymorphisms and coronary heart disease risk: A meta- knockout mice and tideglusib. Front Mol Neurosci.
analysis. BMC Med Genet. 2012;13:39. 2020;13:81.
doi: 10.1186/1471-2350-13-39 doi: 10.3389/fnmol.2020.00081
37. Yeung AWK, Aggarwal BB, Orhan IE, et al. Resveratrol, a 47. Cabral-Pacheco GA, Garza-Veloz I, Castruita-De la Rosa C,
popular dietary supplement for human and animal health: et al. The roles of matrix metalloproteinases and their
Quantitative research literature analysis-a review. Anim Sci inhibitors in human diseases. Int J Mol Sci. 2020;21(24):9739.

Volume 9 Issue 1 (2025) 166 doi: 10.36922/ejmo.8086